Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2002 Canadian Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: geoffb_si who wrote (587)	3/26/2002 3:15:07 PM
From: russet	Read Replies (2) \| Respond to of 1590

ONC.t,... I think the lid is about to get blown off this one shortly,...20 million shares out but the float is only about 8 million,...maybe less. When the cancer patients start asking for Reolysin after the press gets hold of the story (just starting now) it will send our heads spinning. Market cap currently $60 million loonies,...could easily blow past US$1 billion without stopping to catch its breath once it finds its legs. The results are nothing short of spectacular, but because we are only in Phase I, the Canadian press is shy about telling the story because the idiot brokerage/ANALyst industry tells all the sheep not to bother with drug companies with one product pipelines, or ones that haven't entered phase III drug testing. So the story of Reolysin's stunning cancerous tumor eating accomplishment in Phase I is being ignored by most. This is a gift,....but don't forget, I'm only a semi-squished hamster that some people like to kick around,...WTFDIK (gggggggggggggggggg)